KEY FEATURES
| Full Name | Vitronectin |
|---|---|
| Synonym | V75; VN; VNT; Serum Spreading Factor; Somatomedin B; Complement S-Protein |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 6.25-400ng/mL |
| Sensitivity | 2.74ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human VTN in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human VTN. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human VTN and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human VTN, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human VTN. You can calculate the concentration of Human VTN in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human VTN ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 20.27 | 63.97 | 142.64 | 20.88 | 61.95 | 148.62 |
| Standard deviation | 1.28 | 3.81 | 4.34 | 1.15 | 2.75 | 8.04 |
| CV(%) | 6.31 | 5.96 | 3.04 | 5.49 | 4.44 | 5.41 |
RECOVERY
The recovery of Human VTN spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-104 | 99 |
| EDTA plasma (n=8) | 89-104 | 96 |
| Cell culture media (n=8) | 94-106 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human VTN in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with VTN ELISA Kits
| SERPINE1 ELISA Kit | publications with VTN and SERPINE1 |
| PLAUR ELISA Kit | publications with VTN and PLAUR |
| ITGB3 ELISA Kit | publications with VTN and ITGB3 |
| ITGAV ELISA Kit | publications with VTN and ITGAV |
| ITGB5 ELISA Kit | publications with VTN and ITGB5 |
Pathways associated with VTN ELISA Kit
| Complement Cascade Pathway | Complement Cascade Pathway |
| ECM Proteoglycans Pathway | ECM Proteoglycans Pathway |
| ECM-receptor Interaction Pathway | ECM-receptor Interaction Pathway |
| Elastic Fibre Formation Pathway | Elastic Fibre Formation Pathway |
| Extracellular Matrix Organization Pathway | Extracellular Matrix Organization Pathway |
| FOXA1 Transcription Factor Network Pathway | FOXA1 Transcription Factor Network Pathway |
| Focal Adhesion Pathway | Focal Adhesion Pathway |
Diseases associated with VTN ELISA Kit
| Cardiovascular Diseases | publications with VTN and Cardiovascular Diseases |
| Carcinoma, Hepatocellular | publications with VTN and Carcinoma, Hepatocellular |
| Nervous System Diseases | publications with VTN and Nervous System Diseases |
| Fibrosis | publications with VTN and Fibrosis |
| Kidney Diseases | publications with VTN and Kidney Diseases |
| Liver Diseases | publications with VTN and Liver Diseases |
| Liver Cirrhosis | publications with VTN and Liver Cirrhosis |
| Weight Loss | publications with VTN and Weight Loss |
| Disease Models, Animal | publications with VTN and Disease Models, Animal |
| Necrosis | publications with VTN and Necrosis |
Organs/Tissues associated with VTN ELISA Kit
| Brain | publications with VTN and Brain |
| Heart | publications with VTN and Heart |
| Muscle | publications with VTN and Muscle |
| Kidney | publications with VTN and Kidney |
| Eye | publications with VTN and Eye |
| Lung | publications with VTN and Lung |
| Embryonic Tissue | publications with VTN and Embryonic Tissue |